The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo

Hepcidin is widely present in many kinds of fish and is an important innate immune factor. A variety of HAMP2-type hepcidins have strong antimicrobial activity and immunomodulatory functions and are expected to be developed as substitutes for antibiotics. In this study, the antimicrobial activity of...

Full description

Bibliographic Details
Main Authors: Ruihao Gong, Zhe An, Weibin Zhang, Fangyi Chen, Ke-Jian Wang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/20/10/651
_version_ 1827617399525867520
author Ruihao Gong
Zhe An
Weibin Zhang
Fangyi Chen
Ke-Jian Wang
author_facet Ruihao Gong
Zhe An
Weibin Zhang
Fangyi Chen
Ke-Jian Wang
author_sort Ruihao Gong
collection DOAJ
description Hepcidin is widely present in many kinds of fish and is an important innate immune factor. A variety of HAMP2-type hepcidins have strong antimicrobial activity and immunomodulatory functions and are expected to be developed as substitutes for antibiotics. In this study, the antimicrobial activity of Hepc2 from Japanese seabass (<i>Lateolabrax japonicus</i>) (designated as LJ-hep2) was investigated using its recombinant precursor protein (rLJ-hep2) expressed in <i>Pichia pastoris</i> and a chemically synthesized mature peptide (LJ-hep2<sub>(66–86)</sub>). The results showed that both rLJ-hep2 and synthetic LJ-hep2<sub>(66–86)</sub> displayed broad antimicrobial spectrum with potent activity against gram-negative and gram-positive bacteria, and fungi. Especially, LJ-hep2<sub>(66–86)</sub> had stronger antimicrobial activity and exhibited potent activity against several clinically isolated multidrug-resistant bacteria, including <i>Acinetobacter baumannii</i>, <i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i>, <i>Klebsiella pneumoniae</i> and <i>Enterococcus faecium</i>. Moreover, LJ-hep2<sub>(66–86)</sub> exerted rapid bactericidal kinetic (killed tested bacteria within 2 h), induced significant morphological changes and promoted agglutination of <i>E. coli</i>, <i>P. aeruginosa</i> and <i>Aeromonas hydrophila</i>. The activity of LJ-hep2<sub>(66–86)</sub> against <i>E. coli</i>, <i>P. aeruginosa</i> and <i>A. hydrophila</i> was stable and remained active when heated for 30 min. In addition, LJ-hep2<sub>(66–86)</sub> exhibited no cytotoxicity to the mammalian cell line HEK293T and fish cell lines (EPC and ZF4). In vivo study showed that LJ-hep2<sub>(66–86)</sub> could improve the survival rate of marine medaka (<i>Oryzias melastigma</i>) by about 40% under the challenge of <i>A. hydrophila</i>, indicating its immunoprotective function. Taken together, both rLJ-hep2 and LJ-hep2<sub>(66–86)</sub> have good prospects to be used as potential antimicrobial agents in aquaculture and medicine in the future.
first_indexed 2024-03-09T09:45:25Z
format Article
id doaj.art-0645bbd56b904588a22196210dc8fc03
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-09T09:45:25Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-0645bbd56b904588a22196210dc8fc032023-12-02T00:36:26ZengMDPI AGMarine Drugs1660-33972022-10-01201065110.3390/md20100651The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In VivoRuihao Gong0Zhe An1Weibin Zhang2Fangyi Chen3Ke-Jian Wang4State Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361102, ChinaHepcidin is widely present in many kinds of fish and is an important innate immune factor. A variety of HAMP2-type hepcidins have strong antimicrobial activity and immunomodulatory functions and are expected to be developed as substitutes for antibiotics. In this study, the antimicrobial activity of Hepc2 from Japanese seabass (<i>Lateolabrax japonicus</i>) (designated as LJ-hep2) was investigated using its recombinant precursor protein (rLJ-hep2) expressed in <i>Pichia pastoris</i> and a chemically synthesized mature peptide (LJ-hep2<sub>(66–86)</sub>). The results showed that both rLJ-hep2 and synthetic LJ-hep2<sub>(66–86)</sub> displayed broad antimicrobial spectrum with potent activity against gram-negative and gram-positive bacteria, and fungi. Especially, LJ-hep2<sub>(66–86)</sub> had stronger antimicrobial activity and exhibited potent activity against several clinically isolated multidrug-resistant bacteria, including <i>Acinetobacter baumannii</i>, <i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i>, <i>Klebsiella pneumoniae</i> and <i>Enterococcus faecium</i>. Moreover, LJ-hep2<sub>(66–86)</sub> exerted rapid bactericidal kinetic (killed tested bacteria within 2 h), induced significant morphological changes and promoted agglutination of <i>E. coli</i>, <i>P. aeruginosa</i> and <i>Aeromonas hydrophila</i>. The activity of LJ-hep2<sub>(66–86)</sub> against <i>E. coli</i>, <i>P. aeruginosa</i> and <i>A. hydrophila</i> was stable and remained active when heated for 30 min. In addition, LJ-hep2<sub>(66–86)</sub> exhibited no cytotoxicity to the mammalian cell line HEK293T and fish cell lines (EPC and ZF4). In vivo study showed that LJ-hep2<sub>(66–86)</sub> could improve the survival rate of marine medaka (<i>Oryzias melastigma</i>) by about 40% under the challenge of <i>A. hydrophila</i>, indicating its immunoprotective function. Taken together, both rLJ-hep2 and LJ-hep2<sub>(66–86)</sub> have good prospects to be used as potential antimicrobial agents in aquaculture and medicine in the future.https://www.mdpi.com/1660-3397/20/10/651<i>Lateolabrax japonicus</i>hepcidinantimicrobial peptideantimicrobial activitymultidrug-resistant bacteriaimmunoprotective effect
spellingShingle Ruihao Gong
Zhe An
Weibin Zhang
Fangyi Chen
Ke-Jian Wang
The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo
Marine Drugs
<i>Lateolabrax japonicus</i>
hepcidin
antimicrobial peptide
antimicrobial activity
multidrug-resistant bacteria
immunoprotective effect
title The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo
title_full The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo
title_fullStr The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo
title_full_unstemmed The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo
title_short The Antimicrobial Peptide LJ-hep2 from <i>Lateolabrax japonicus</i> Exerting Activities against Multiple Pathogenic Bacteria and Immune Protection In Vivo
title_sort antimicrobial peptide lj hep2 from i lateolabrax japonicus i exerting activities against multiple pathogenic bacteria and immune protection in vivo
topic <i>Lateolabrax japonicus</i>
hepcidin
antimicrobial peptide
antimicrobial activity
multidrug-resistant bacteria
immunoprotective effect
url https://www.mdpi.com/1660-3397/20/10/651
work_keys_str_mv AT ruihaogong theantimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT zhean theantimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT weibinzhang theantimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT fangyichen theantimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT kejianwang theantimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT ruihaogong antimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT zhean antimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT weibinzhang antimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT fangyichen antimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo
AT kejianwang antimicrobialpeptideljhep2fromilateolabraxjaponicusiexertingactivitiesagainstmultiplepathogenicbacteriaandimmuneprotectioninvivo